Press Release Details - Smiths Group plc

Cookies

The cookie settings on this website are set to ‘allow all cookies’. Leaving your settings to ‘allow all cookies’ means you consent to a website remembering your preferences and generally enhancing the user experience. If you prefer a website to not remember your preferences, you can change your settings at any time by changing the privacy settings of your browser.

Find out more about cookies >

28 September 2016

Annual results for the year ended 31 July 2016


Robust results lay foundations for future growth

 

Highlights

  • Growth in reported revenue and headline operating profit in four out of five divisions
  • Group revenue declined 2% on an underlying1 basis; up 2% on a reported basis
  • 53% of Group revenues derived from aftermarket and consumables
  • Headline operating profit declined 4% on an underlying1 basis, driven by tough global energy market conditions for John Crane
  • Good margin expansion in Smiths Medical, Smiths Detection and Smiths Interconnect
  • John Crane margins resilient at 21.9%; Flex-Tek margins stable
  • Earnings per share of 85.2 pence fell 1% year-on-year driven by higher finance costs
  • 102% cash conversion drove an underlying reduction in net debt
  • Proposed final dividend of 28.75 pence per share. Full year dividend growth of 2.4%
  • $710m acquisition of Morpho Detection expected to complete in early 2017, subject to regulatory clearances

1 Underlying excludes the impact of acquisitions and divestments, and the effects of foreign exchange translation

 

Results for the year ended 31 July 2016

  Headline* Statutory
  2016
£m
2015
£m
Reported growth Underlying growth# 2016
£m
2015
£m
Revenue 2,949 2,897 2% (2)% 2,949 2,897
Operating profit 510 511 (4)% 387 394
Operating margin 17.3% 17.6% (30) bps (40)bps 13.1% 13.6%
Pre-tax profit 451 459 (2)% (5)% 346 325
Basic EPS 85.2p 86.1p (1)%   65.6p 62.4p
Headline free cash-flow 400 339 18%      
Dividend 42.00p 41.00p 2%      
Return on capital employed 15.3% 16.0% (70)bps      

*In addition to statutory reporting, Smiths Group reports its continuing operations on a headline basis. Definitions of headline metrics, and information about the adjustments to statutory measures are provided in the notes to the financial statements

#Organic growth adjusting for foreign exchange translation

 

Andy Reynolds Smith, Group Chief Executive, commented:

“Smiths Group delivered a robust performance this year. We achieved good growth in headline operating profits with associated margin expansion in our Medical, Detection and Interconnect divisions, driven by revenue growth and business improvement initiatives. However, significant headwinds in the global energy markets impacted John Crane, primarily in the sales of first-fit equipment; aftermarket was more resilient with underlying revenue down 4%. For Smiths Group as a whole, more than half of our revenue continued to come from the recurring aftermarket for our products and services.

“In the first year as CEO, my aim has been to lay the foundations for future value creation through stronger growth, improved competitiveness, more robust and consistent execution and a better focused portfolio. We have undertaken a strategic review across the Group to examine in detail the sustainable growth characteristics of the markets we serve and our competitive positioning within those markets. We start from a solid base with a Group of well-run and well-positioned businesses, with nearly two-thirds of Group revenues coming from market segments that have attractive growth rates. We see clear potential to increase our exposure to faster growing market segments and to improve our overall market competitiveness in the medium term as we take steps to focus our portfolio.

“Our strategic review gives us a clearer sense of where to focus investment in order to drive future growth and technological differentiation, and we have aligned our capital allocation process accordingly. As a result, we were able to commit $710m for the acquisition of Morpho Detection, and to make progress on the disposal of non-core assets. We will increase expenditure on research and development by around £20m in the coming year to invest in future growth opportunities, with a particular focus on our digital future. In parallel, we are implementing measures across the business to ensure continuous improvement and greater consistency of execution in everything we do in order to deliver productivity improvements across the Group. I am confident that, over the long term, our strategy will drive Smiths to become one of the world’s leading technology companies.

“We anticipate a broad continuation of the trends experienced in 2016, with ongoing challenges in John Crane’s end markets being more than offset by moderate underlying revenue growth in our other divisions. As is typically the case, Group performance in 2017 is expected to be weighted towards the second half. We expect cash conversion to continue to be strong in the coming year and the recent depreciation of sterling is expected to provide a tailwind to reported revenue and operating profit, should current rates prevail.”



Statutory reporting
Statutory reporting takes account of all items excluded from headline performance. On a statutory basis, pre-tax profit from continuing operations was £346m (2015: £325m) and earnings per share were 65.6p (2015: 62.4p).

See Accounting policies for an explanation of the presentation of results and note 3 to the accounts for an analysis of non-headline items.

 

To view the full press release please click here

 

Contact details

Investor enquiries
Andrew Lappin, Smiths Group
+44 (0)20 7004 1657
+44 (0)78 0500 7035
andrew.lappin@smiths.com

Kirsty Law, Smiths Group
+44 (0)20 7004 1672
+44 (0)75 8315 4386
kirsty.law@smiths.com

Media enquiries
Andrew Lorenz, FTI Consulting
+44 (0)20 3727 1323
+44 (0)77 7564 1807
smiths@fticonsulting.com

 

Presentation
The presentation slides and a live webcast of the presentation to analysts are available www.smiths.com/results at 09.00 (UK time) on Wednesday 28 September. A recording of the webcast is available later that day. A live audio broadcast of the presentation is also available by dialling (no access code required):

UK toll free: 0808 237 0035
International: +44 (0)20 3426 2887
US/Canada toll free: +1 877 841 4558

An audio replay is available for seven days on the following numbers (access PIN 676001#):

UK toll free: 0808 237 0026
International: +44 (0)20 3426 2807
US/Canada toll free: +1 866 535 8030

Photography
Original high-resolution photography and broadcast quality video is available to the media from the media contacts above or from http://www.smiths.com/images.aspx.

This document contains certain statements that are forward-looking statements. They appear in a number of places throughout this document and include statements regarding our intentions, beliefs or current expectations and those of our officers, directors and employees concerning, amongst other things, our results of operations, financial condition, liquidity, prospects, growth, strategies and the business we operate. By their nature, these statements involve uncertainty since future events and circumstances can cause results and developments to differ materially from those anticipated. The forward-looking statements reflect knowledge and information available at the date of preparation of this document and, unless otherwise required by applicable law, the Company undertakes no obligation to update or revise these forward-looking statements. Nothing in this document should be construed as a profit forecast. The Company and its directors accept no liability to third parties in respect of this document save as would arise under English law.

This press release contains brands that are trademarks and are registered and/or otherwise protected in accordance with applicable law.








back to top

Smiths Group divisions:

John Crane, Smiths Medical, Smiths Detection, Smiths Interconnect, Flex-Tek

Smiths Group plc:
Registered office 4th Floor, 11-12 St James’s Square, London, SW1Y 4LB
Incorporated in England No. 137013
Copyright 2017 Smiths Group plc.
All rights Reserved | Legal Notice | Privacy Policy | Cookie Policy